MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-12-2023
PolarityTE DPO Ratio 2011-2026 | PTE
Annual DPO Ratio PolarityTE
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 187 | 57.8 | 98.4 | 249 | 731 | - | 166 | 51.1 | 17.9 | 46.1 | 19.9 | 27.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 731 | 17.9 | 150 |
Quarterly DPO Ratio PolarityTE
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 61.5 | 435 | 82.3 | - | 52 | 29.8 | 32.3 | - | 80.5 | 123 | 255 | - | 239 | 259 | 271 | 699 | 399 | 1.6 K | 151 K | 38.5 K | - | - | - | 522 | - | 214 | 269 | 23.4 | 12.9 | 119 | 413 | 10.4 | 5.45 | 72.3 | 77.3 | 23.5 | 15.7 | 146 | 30.3 | - | 3.3 | 78.6 | 12.1 | 0.02 | 0.01 | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 151 K | 0.01 | 5.31 K |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B |  USA |
 |
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | USA |
 |
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | USA |
 |
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - |  Russia |
 |
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M |  Israel |
 |
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
bluebird bio
BLUE
|
182 | - | - | $ 546 M | USA |
 |
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | USA |
 |
CASI Pharmaceuticals
CASI
|
123 | - | - | $ 35.4 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | USA |
 |
Завод ДИОД
DIOD
|
30.3 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
306 | - | - | - | Russia |
 |
Chimerix
CMRX
|
2.38 K | - | - | $ 756 M | USA |
 |
Teligent, Inc.
TLGT
|
59.2 | - | -13.85 % | $ 16.1 M | USA |
 |
AbbVie
ABBV
|
65.5 | $ 208.7 | -0.07 % | $ 369 B | USA |
 |
Viela Bio, Inc.
VIE
|
997 | - | - | $ 2.91 B | USA |